Blog
Zapata Quantum Bets Software, AI Partnerships Will Unlock Quantum Computing Value
Key Points
- Interested in Zapata Quantum? Here are five stocks we like better.
- Zapata Quantum says the quantum industry is shifting from hardware to software and applications, and that its
Contango ORE Drops Gold Hedges to Boost Upside as Manh Choh Output Ramps
Key Points
- Interested in Contango ORE, Inc.? Here are five stocks we like better.
- Contango ORE removed its remaining gold hedge book by converting the last 15,000 hedged ounces into debt
Zeta Global Eyes AI Infrastructure Shift as Palantir Integration Nears
Key Points
- Interested in Zeta Global Holdings Corp.? Here are five stocks we like better.
- Zeta Global said it is shifting beyond marketing technology and positioning itself as an AI
Whitestone REIT Shareholders Approve AREG Merger, Reject Executive Pay Plan
Key Points
- Interested in Whitestone REIT? Here are five stocks we like better.
- Whitestone REIT shareholders approved the company’s merger with AREG Wizard Intermediate LP at a virtual special
Unum Group Cuts Long-Term Care Risk With $3.8B Reinsurance Deal
Key Points
- Interested in Unum Group? Here are five stocks we like better.
- Unum Group agreed to reinsure an additional $3.8 billion of long-term care statutory reserves with Fortitude Re
Teva Pharmaceutical Industries’ Anti-IL-15 Antibody Shows Promise in Vitiligo Study
Key Points
- Interested in Teva Pharmaceutical Industries Ltd.? Here are five stocks we like better.
- Teva’s anti-IL-15 antibody showed encouraging 24-week results in a phase 1b vitiligo study
Dr. Reddy's Laboratories Flags Semaglutide Supply Delay, Says No Recall Risk
Key Points
- Interested in Dr. Reddy's Laboratories Ltd? Here are five stocks we like better.
- Dr. Reddy’s Laboratories said a scale-up issue involving the API for its semaglutide injection will
Planet Labs PBC Shareholders Back Directors, KPMG and Pay Plan at Annual Meeting
Key Points
- Interested in Planet Labs PBC? Here are five stocks we like better.
- Planet Labs shareholders backed all three management proposals at the 2026 annual meeting, including the
MasTec Bets Big on AI Infrastructure With $1.65B Superior Group Deal
Key Points
- Interested in MasTec, Inc.? Here are five stocks we like better.
- MasTec is buying Superior Group for about $1.65 billion, with the deal structured as $1.175 billion in cash, $475
Element Solutions Lands $14.5B Solstice Deal as AI Data Center Demand Booms
Solstice Advanced Materials said it has agreed to acquire Element Solutions (NYSE:ESI) in a cash-and-stock transaction valued at approximately
Equifax Expands in Mexico With $750 Million Círculo de Crédito Deal
Key Points
- Interested in Equifax, Inc.? Here are five stocks we like better.
- Equifax has agreed to buy Mexico’s Círculo de Crédito for an enterprise value of $750 million, marking a major
3 Rare-Earth ETFs That Help Investors Balance Exposure and Risk
Key Points
- Interested in VanEck Rare Earth and Strategic Metals ETF? Here are five stocks we like better.
- China's rare-earth dominance stems from decades of investment in refining and processing
Dycom Industries Says Fiber, Data Center Demand Gives Backlog ‘Staying Power’
Key Points
- Interested in Dycom Industries, Inc.? Here are five stocks we like better.
- Dycom sees lasting demand from fiber, long-haul networks and data center projects, with CEO Dan Peyovich
Microsoft Bets on In-House AI to Cut OpenAI and Anthropic Costs
Key Points
- Interested in Microsoft Corporation? Here are five stocks we like better.
- Microsoft is routing some Excel and Outlook prompts to its own MAI models instead of OpenAI or Anthropic to
Delta Air Lines Lives Up to Its Claims: Shares Can Keep Climbing
Key Points
- Interested in Delta Air Lines, Inc.? Here are five stocks we like better.
- Delta Air Lines reported strong Q2 2026 results with revenue up 30.3% and raised guidance, prompting 27
Why "Big Short" Investor Michael Burry Sees Upside in Beaten-Down Sportbook Stocks
Key Points
- Interested in Flutter Entertainment PLC? Here are five stocks we like better.
- Michael Burry recently bought shares of DraftKings and Flutter Entertainment, betting on a recovery in
Capri Charts Post-Versace Comeback With Michael Kors Revamp, Jimmy Choo Growth
Key Points
- Interested in Capri Holdings Limited? Here are five stocks we like better.
- Capri is refocusing after selling Versace, with management now concentrating on Michael Kors and Jimmy
Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business
Key Points
- Interested in Clarivate PLC? Here are five stocks we like better.
- Clarivate will sell substantially all of its Life Sciences & Healthcare segment to Altaris for $600 million, with
Chewy Annual Meeting: Directors Elected, Deloitte Ratified and Pay Vote Approved
Key Points
- Interested in Chewy? Here are five stocks we like better.
- At Chewy’s 2026 Annual Meeting, shareholders elected all five Class I director nominees to three-year terms ending at the
AstraZeneca Updates 2030 Sustainability Goals as AI and Emissions Cuts Take Center Stage
Key Points
- Interested in Astrazeneca Plc? Here are five stocks we like better.
- AstraZeneca updated its 2030 sustainability targets, lowering its Scope 3 emissions goal to a 35% reduction from
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse
Key Points
- Interested in Vertex Pharmaceuticals Incorporated? Here are five stocks we like better.
- Vertex Pharmaceuticals agreed to buy Crinetics Pharmaceuticals for $85 per share in cash
Veritone Shareholders Back Share Increase, CEO Awards as Debt Questions Loom
Key Points
- Interested in Veritone, Inc.? Here are five stocks we like better.
- Veritone shareholders approved all six proposals at the 2026 annual meeting, including re-electing two directors
Veritone Maps AI Growth Push as Oracle Partnership Targets Cost Savings
Key Points
- Interested in Veritone, Inc.? Here are five stocks we like better.
- Veritone outlined a broad AI strategy centered on turning unstructured data like video, audio and documents into
Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgA Nephropathy, Sets Launch
Key Points
- Interested in Vera Therapeutics, Inc.? Here are five stocks we like better.
- Vera Therapeutics won accelerated FDA approval for TRUTAKNA (atacicept-vymj) to treat adults with primary
Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout
Key Points
- Interested in Turn Therapeutics Inc.? Here are five stocks we like better.
- Turn Therapeutics refined the stage two design of its GX-03 phase II eczema trial after an interim